Skip to the study brief

ECLEVAR MedTech · Medical device CRO

Surgical robotics clinical trials in the U.S. and Europe

ECLEVAR designs and runs robot-assisted surgery trials. Get a plan for selecting hospitals, qualifying surgeons and budgeting for each site.

Articulated surgical robot arms at the operating table, with a separate console for the surgeon
Illustration of a robot-assisted operating room

Who would work on your robotics trial?

Meet the clinical consultants who can help design your trial and the business development lead who coordinates your proposal. Your proposal names the study lead and clinical contact for each country.

Michael McGuffey

Michael McGuffey

U.S. Clinical Consultant

On Medtronic’s Hugo™ robotic-assisted surgery launch team, Michael was clinical lead for final labeling. He helped design surgeon training and proctoring for the global launch and started a clinical registry for the platform.

For your study, he can review how surgeons qualify, what the proctor records and what the sponsor should see before opening the next site.

Michael’s professional background
Dawn Heimer

Dawn Heimer, PhD

U.S. Clinical Consultant

Clinical research leader specializing in clinical development strategy, program planning, and FDA interactions. Guides programs through critical milestones, complex situations, and regulatory challenges from early development to market authorization. Conveniently located in the Northeast corridor.

Karina Schönborn

Karina Schönborn

Head of Business Development

Karina is your first contact for a robotics proposal. She works with you and the clinical team to define the study scope, timeline and budget for each country.

Email Karina’s proposal team

Clinical work for JRI Orthopaedics and Coloplast

Two questions matter in robotics studies. Can you link a technical result to a patient outcome? Can different sites measure it the same way? These device programs show how ECLEVAR approaches each question.

Orthopedic implant investigation

JRI Orthopaedics

ECLEVAR’s work

For an ongoing ceramic hip resurfacing investigation, ECLEVAR helped design the endpoints, follow-up schedule and statistical methods. The plan links early imaging and hip function to later revisions and implant survival.

What this means for your trial

If your robot improves placement, you can link each patient’s placement image to later function or revision. Plan that link before enrollment.

Urology study in three countries

Coloplast

ECLEVAR’s work

The CP348 catheter study scope included crossover design, feasibility, submissions, training and monitoring. The plan called for 72 participants in Denmark, France and the UK, with up to four clinic visits each.

What this means for your trial

When operator technique can change a result, hospitals need the same training and definitions. Agree in advance how every team will record an interruption or a conversion.

What does your robot need to demonstrate?

Start with the clinical claim and the decision the study must support. Those choices determine the comparator, endpoint and follow-up period.

Study questions and evidence by surgical robotics application
ApplicationStudy questionWhat to collect
Soft-tissue and urologic surgeryCan surgeons complete the intended procedure with the assigned platform?Record conversions, extra assistance and postoperative complications. If laparoscopy is the comparator, document experience with both techniques.
Orthopedic and spine navigationDoes achieved placement match the plan, and does that matter to patients?Specify who reads the images. Agree when to measure pain, function or revision and how to handle missing follow-up.
New instrument or software releaseWhich clinical tasks change with the new version?Record the instrument and software used in each case and when each site switched. Identify retraining, amendments and the cases affected.

Can the operating room deliver the study?

A busy hospital may have only one operating list where the robot, trained team and research coordinator are all available. Check that list before committing to an enrollment forecast.

  1. Check likely enrollment

    Review recent procedures, competing studies and scheduled room access. Ask each investigator to confirm the assumptions behind their site’s forecast.

  2. Qualify the room and team

    Check installation, instruments and hospital credentialing. Name who trains the console surgeon and bedside team, and who signs off a replacement operator.

  3. Review the first cases together

    Agree how proctor assistance is recorded and which events trigger sponsor review. Compare interruptions, conversions and missing device records before expanding enrollment.

  4. Follow the patient after discharge

    Name the coordinator who will trace readmissions or reinterventions at another hospital. Define the visit window and the source record needed to verify each outcome.

Robotic surgery endpoints, from incision to follow-up

A surgeon may switch to laparoscopy and the patient may recover well. The protocol should say how reviewers will count the conversion and assess the patient’s recovery.

Three records behind a robotic surgery endpoint
  1. Before surgery

    Record indication, complexity, surgeon experience and planned configuration.

    SourceBaseline case record
  2. In the operating room

    Reconcile the operative note with system events, assistance and any change of approach.

    SourceOperative note and device log
  3. At follow-up

    Check complications and reinterventions within the agreed window.

    SourcePatient follow-up record

Account for the surgeon learning curve

Record each surgeon’s case order, prior experience and proctor support. Shorter console times may reflect familiarity or simpler cases. Account for both before comparing sites.

Published example from Medtronic

Medtronic’s Expand URO study enrolled 144 people across six U.S. centers. Of those, 137 underwent a procedure. The researchers evaluated completion without conversion and major complications at 30 days. Your protocol should say whether each endpoint applies to everyone enrolled or to the patients who underwent surgery.

Read the peer-reviewed Expand URO study
How would a conversion be counted?

Suppose an instrument fault interrupts a robotic procedure and the surgeon finishes laparoscopically. Under a protocol defining success as completion with the assigned platform, record a conversion. Assess the patient’s safety outcome separately. The operative note, device event and follow-up record should all refer to the same case.

Opening trial sites in the U.S., EU and UK

Start with hospitals that have the platform, trained surgeons and eligible patients. Compare what each market requires to open a site and which local costs belong in your proposal.

United States

Before sites open
We assess the FDA investigational device exemption (IDE) route and can help prepare pre-submission questions. Significant-risk device studies need FDA and institutional review board approval before starting.
Budget items
Hospital contracts, proctor coverage and monitoring by site.

European Union

Before sites open
We can assess hospitals in France, Germany, Italy or Spain. The type of investigation and the Member States selected determine the authority and ethics steps.
Budget items
Country submissions, translations, site activation and local monitoring.

United Kingdom

Before sites open
For Great Britain, we check whether MHRA notification applies and identify ethics and hospital approvals. Northern Ireland follows a distinct route.
Budget items
Submissions for each jurisdiction, hospital contracts and site activation.

FDA published draft recommendations on premarket submissions for robotically assisted surgical devices in September 2026. Its draft status matters when preparing questions for the agency. Read the FDA draft

Build your surgical robotics study brief

Choose a study stage and a market to see the clinical work and budget assumptions for your trial. Copy the brief for your team or discuss it with Karina.

Scope by study stage

Pick the stage and market below that fit your program. Include their listed assumptions when you contact the clinical team.

First clinical cases
Site-readiness checklist, surgeon training record and a first-case review plan with criteria for opening the next site.
Installed systems, proctor days, supported first cases per surgeon and technical cover.
Pivotal investigation
Comparator and endpoint rationale, investigator qualification criteria, monitoring plan and statistical analysis outline.
Sites and surgeons per arm, case volume, independent outcome review and follow-up visits.
Post-market follow-up
Evidence-gap review, follow-up protocol, device-version tracking and a plan for tracing revisions or reinterventions.
Patients per site, years of follow-up, record retrieval and frequency of reports.
United States
Assess the applicable FDA and IRB steps, site contracts and proctor coverage before assigning U.S. activation dates.
European Union
Compare candidate Member States and identify country submissions, ethics review, translations and local monitors.
United Kingdom
Identify sites in Great Britain and Northern Ireland separately, then confirm notification, ethics and hospital requirements for each.
U.S. and Europe
Map a common protocol to U.S. and European requirements. Price country-specific tasks and show which hospitals can open first.

Already have a synopsis? Share the target procedure, countries and decision date through the proposal form or email clientcare@eclevar.com.

Back to page sections